<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Meng Z</submitter><pubmed_abstract>Targeting mitochondria via nano platform emerged as an attractive anti-tumor pathway due to the central regulation role in cellar apoptosis and drug resistance. Here, a mitochondria-targeting nanoparticle (TOS-PDA-PEG-TPP) was designed to precisely deliver polydopamine (PDA) as the photothermal agent and alpha-tocopherol succinate (α-TOS) as the chemotherapeutic drug to the mitochondria of the tumor cells, which inhibits the tumor growth through chemo- and photothermal- synergistic therapies. TOS-PDA-PEG-TPP was constructed by coating PDA on the surface of TOS NPs self-assembled by α-TOS, followed by grafting PEG and triphenylphosphonium (TPP) on their surface to prolong the blood circulation time and target delivery of TOS and PDA to the mitochondria of tumor cells. &lt;i>In vitro&lt;/i> studie</pubmed_abstract><journal>Regenerative biomaterials</journal><pagination>rbac051</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9362997</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer.</pubmed_title><pmcid>PMC9362997</pmcid><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Tu P</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Wan Y</pubmed_authors><pubmed_authors>Meng Z</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Liang R</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors><pubmed_authors>Wu H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer.</name><description>Targeting mitochondria via nano platform emerged as an attractive anti-tumor pathway due to the central regulation role in cellar apoptosis and drug resistance. Here, a mitochondria-targeting nanoparticle (TOS-PDA-PEG-TPP) was designed to precisely deliver polydopamine (PDA) as the photothermal agent and alpha-tocopherol succinate (α-TOS) as the chemotherapeutic drug to the mitochondria of the tumor cells, which inhibits the tumor growth through chemo- and photothermal- synergistic therapies. TOS-PDA-PEG-TPP was constructed by coating PDA on the surface of TOS NPs self-assembled by α-TOS, followed by grafting PEG and triphenylphosphonium (TPP) on their surface to prolong the blood circulation time and target delivery of TOS and PDA to the mitochondria of tumor cells. &lt;i>In vitro&lt;/i> studie</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T10:44:55.277Z</modification><creation>2025-04-04T10:44:55.277Z</creation></dates><accession>S-EPMC9362997</accession><cross_references><pubmed>35958515</pubmed><doi>10.1093/rb/rbac051</doi></cross_references></HashMap>